SGMT
Sagimet Biosciences Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.94
+0.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 680.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.65x
- Price / sales
- —
- Price / cash flow
- -16.46x
Enterprise value
- Enterprise value
- $441.8M
- EV / sales
- —
- EV / EBITDA
- -8.89x
- EV / EBIT
- -8.39x
- Market cap
- $680.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026